CARD19

Chr 9

caspase recruitment domain family member 19

Also known as: BinCARD, C9orf89

The protein inhibits NF-kappaB signaling by blocking BCL10-induced activation and may prevent BCL10 phosphorylation through its CARD domain. This gene is extremely intolerant to loss-of-function variants (pLI near 1.0), suggesting mutations would likely cause severe disease, though specific associated phenotypes have not yet been established. The inheritance pattern for pathogenic variants in this gene has not been determined.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.41
Clinical SummaryCARD19
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
29 unique Pathogenic / Likely Pathogenic· 38 VUS of 78 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.41LOEUF
pLI 0.000
Z-score 0.59
OE 0.81 (0.491.41)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.05Z-score
OE missense 0.99 (0.851.15)
119 obs / 120.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.81 (0.491.41)
00.351.4
Missense OE0.99 (0.851.15)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 9 / 11.1Missense obs/exp: 119 / 120.5Syn Z: -0.03
DN
0.6260th %ile
GOF
0.75top 25%
LOF
0.4233th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

78 submitted variants in ClinVar

Classification Summary

Pathogenic26
Likely Pathogenic3
VUS38
Likely Benign1
26
Pathogenic
3
Likely Pathogenic
38
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
26
0
26
Likely Pathogenic
0
0
3
0
3
VUS
0
35
3
0
38
Likely Benign
0
0
0
1
1
Benign
0
0
0
0
0
Total03532168

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CARD19 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 2 results · since 2015Search PubMed ↗